ABBOTT LABORATORIES — Director's Dealing 2017

Nov 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-11-17

Reporting Person: Blaser Brian J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-17	Common shares without par value	M	3233	$26.1879	Acquired	146387	Direct
2017-11-17	Common shares without par value	M	6333	$23.2280	Acquired	152720	Direct
2017-11-17	Common shares without par value	S	2700	$55.5750	Disposed	150020	Direct
2017-11-17	Common shares without par value	S	1000	$55.5710	Disposed	149020	Direct
2017-11-17	Common shares without par value	S	3944	$55.5700	Disposed	145076	Direct
2017-11-17	Common shares without par value	S	1922	$55.5650	Disposed	143154	Direct
2017-11-17	Common shares without par value	S	2000	$55.53	Disposed	141154	Direct
2017-11-17	Common shares without par value	S	900	$55.5301	Disposed	140254	Direct
2017-11-17	Common shares without par value	S	713	$55.531	Disposed	139541	Direct
2017-11-17	Common shares without par value	S	200	$55.532	Disposed	139341	Direct
2017-11-17	Common shares without par value	S	200	$55.5321	Disposed	139141	Direct
2017-11-17	Common shares without par value	S	10287	$55.535	Disposed	128854	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-17	Option (right to buy)	$26.1879	M	3233	Disposed	2020-02-18	Common shares (3233)	Direct
2017-11-17	Option (right to buy)	$23.2280	M	6333	Disposed	2020-05-16	Common shares (6333)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.